Frontiers in ophthalmology最新文献

筛选
英文 中文
Development and internal validation of a prediction model for new-onset macular oedema following vitrectomy for diabetic retinopathy: a single-centre retrospective analysis. 糖尿病视网膜病变玻璃体切除术后新发黄斑水肿预测模型的建立和内部验证:单中心回顾性分析。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-29 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1932517
Jiayu Ma, Jing Wang, Yiwei Wang, Chenyu Yang, Jiahao Li, Yingjun Li
{"title":"Development and internal validation of a prediction model for new-onset macular oedema following vitrectomy for diabetic retinopathy: a single-centre retrospective analysis.","authors":"Jiayu Ma, Jing Wang, Yiwei Wang, Chenyu Yang, Jiahao Li, Yingjun Li","doi":"10.3389/fopht.2026.1932517","DOIUrl":"https://doi.org/10.3389/fopht.2026.1932517","url":null,"abstract":"<p><strong>Objective: </strong>To develop and internally validate a compact model for estimating the 1-year risk of new-onset postoperative macular oedema in patients with diabetic retinopathy undergoing vitrectomy.</p><p><strong>Methods: </strong>This single-centre retrospective cohort included 650 recorded patients treated from January 2023 to April 2025. The primary analysis comprised 607 patients with ascertainable 1-year outcomes, with one study eye per patient; 43 patients lost to follow-up were assessed separately. New-onset macular oedema required new intraretinal cystoid spaces and/or subretinal fluid on optical coherence tomography during postoperative days 30-365, together with central macular thickness ≥300 μm or an increase ≥30 μm from baseline. The five-predictor logistic model used pre-incision measurements and was fitted in all 607 patients. Internal validation used 1, 000 bootstrap resamples; a 32-candidate, 10-fold cross-validated least absolute shrinkage and selection operator (LASSO) analysis with selection-inclusive bootstrap validation assessed the stability of the separate LASSO procedure.</p><p><strong>Results: </strong>New-onset postoperative macular oedema occurred in 207 of 607 patients (34.1%). The apparent area under the receiver operating characteristic curve (AUC) was 0.823 and the optimism-corrected AUC was 0.818. The corresponding Brier scores were 0.159 and 0.163; the corrected calibration intercept and slope were -0.011 and 0.969. At an illustrative probability threshold of 0.30, 40 of 323 patients (12.4%) in the lower-risk group and 167 of 284 (58.8%) in the higher-risk group developed the outcome. Selection-inclusive validation of the LASSO sensitivity model yielded a corrected AUC of 0.805. Systolic pressure was not statistically significant in the five-predictor model (P = 0.329).</p><p><strong>Conclusion: </strong>The five-variable model showed useful discrimination and acceptable bootstrap-corrected calibration in this single-centre cohort. It should be regarded as an internally validated risk-stratification model that requires external and prospective validation before clinical implementation.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1932517"},"PeriodicalIF":2.4,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13754739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lacrimal gland adenoid cystic carcinoma: a rare case report. 泪腺腺样囊性癌1例报告。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-29 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1936845
Estefania Ramírez Marquez, Maria Garcia Forestier, Maria Correa, Joseph Campbell
{"title":"Lacrimal gland adenoid cystic carcinoma: a rare case report.","authors":"Estefania Ramírez Marquez, Maria Garcia Forestier, Maria Correa, Joseph Campbell","doi":"10.3389/fopht.2026.1936845","DOIUrl":"https://doi.org/10.3389/fopht.2026.1936845","url":null,"abstract":"<p><p>Lacrimal gland adenoid cystic carcinoma (LGACC) is a rare and aggressive malignancy characterized by perineural invasion, late recurrence, and high mortality. No consensus treatment guidelines exist, and management strategies range from eye-sparing excision to orbital exenteration combined with chemotherapy and radiotherapy. This report describes a 32-year-old Hispanic man with a six-year history of right orbital pressure that progressed to pain, diplopia, and lacrimation. Clinical examination revealed 20/20 visual acuity bilaterally, a palpable right upper eyelid mass, and hypoglobus with inferonasal globe displacement. Imaging identified a well-defined right lacrimal gland mass, and biopsy confirmed adenoid cystic carcinoma. Intra-arterial chemoreduction was not feasible; however, three cycles of systemic cisplatin and doxorubicin resulted in no radiographic tumor reduction. The patient subsequently underwent right orbital exenteration, followed by adjuvant radiotherapy, and remains under multidisciplinary surveillance, with no evidence of local recurrence at 34 months of follow-up. LGACC is best managed with an individualized, interdisciplinary, and multimodal approach. Given the lack of consensus guidelines and the risk of late recurrence, long-term monitoring is essential, and further research is required to establish surveillance and management strategies.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1936845"},"PeriodicalIF":2.4,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13754877/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photothermal foveal injury secondary to accidental alexandrite-laser exposure: a case report and literature review. 意外亚历山大宝石激光照射继发光热中央凹损伤1例报告及文献复习。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-28 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1948525
Marya Allan, Sana' Muhsen, Eman Yaseen, Nisreen Sawafta, Mousa Alfoqahaa
{"title":"Photothermal foveal injury secondary to accidental alexandrite-laser exposure: a case report and literature review.","authors":"Marya Allan, Sana' Muhsen, Eman Yaseen, Nisreen Sawafta, Mousa Alfoqahaa","doi":"10.3389/fopht.2026.1948525","DOIUrl":"10.3389/fopht.2026.1948525","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of alexandrite laser-induced foveal injury complicated by acute anterior uveitis, which showed a significant clinical improvement over serial follow-up.</p><p><strong>Observations: </strong>We report the case of a 23-year-old female, a laser hair removal technician, who presented with sudden central visual loss in her left eye (LE) after an accidental exposure to an alexandrite laser beam while cleaning the probe. At the initial presentation, visual acuity (VA) of the LE was 0.1. Optical coherence tomography (OCT) demonstrated a loss of the foveal depression with a vertical hyperreflective column extending from the inner retinal layers to the retinal pigment epithelium (RPE), with focal disruption of the ellipsoid zone (EZ) and the external limiting membrane (ELM) at the fovea. Over 5 months with regular follow-up, VA improved to 1.0. OCT demonstrated residual central foveal disruption with localized attenuation of the EZ and RPE, confined to a smaller area compared with baseline.</p><p><strong>Conclusions and importance: </strong>This case demonstrates the importance of safety protocols when handling laser devices to prevent accidental eye injuries, and demonstrates the potential for good clinical outcomes with regular evaluation and follow-ups.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1948525"},"PeriodicalIF":2.4,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implantable collamer lens surgery for high myopia: safety boundaries, vault management, and patient selection. 高度近视的植入式晶状体手术:安全界限、拱顶管理和患者选择。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-27 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1908210
Zitong Yu, Tong Qin
{"title":"Implantable collamer lens surgery for high myopia: safety boundaries, vault management, and patient selection.","authors":"Zitong Yu, Tong Qin","doi":"10.3389/fopht.2026.1908210","DOIUrl":"10.3389/fopht.2026.1908210","url":null,"abstract":"<p><p>Posterior chamber implantable collamer lens (ICL) implantation provides additive refractive correction for selected phakic patients, especially those with high myopia and limited corneal laser options. This narrative Mini Review synthesizes literature published mainly from January 2021 through May 2026 to connect patient selection with measurable safety boundaries, separate lens power and size planning, dynamic vault assessment, and long-term surveillance. It also discusses hyperopic ICLs, non-EVO lenses, alternative phakic IOL platforms such as IPCL, and emerging artificial intelligence. True anterior chamber depth, age-appropriate endothelial reserve, open angles, crystalline lens status, and refractive stability define eligibility. Central vault is interpreted using pragmatic numerical categories alongside angle, pressure, and lens findings; no single vault threshold guarantees safety or mandates exchange. Refractive and vault prediction models have different inputs and outcomes, and favorable average accuracy does not establish performance in extreme or underrepresented anatomy. Modern central-port ICLs show good outcomes in appropriately selected myopic eyes, while evidence for hyperopic and alternative platforms is smaller and not interchangeable. The proposed clinical framework represents expert synthesis rather than a validated decision rule. Future priorities include externally validated multimodal prediction and prospective lifelong safety monitoring.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1908210"},"PeriodicalIF":2.4,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13749031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149388851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
V-pattern with diplopia following bilateral lateral rectus recession in intermittent exotropia. 间歇性外斜视伴双侧直肌萎缩后的v型复视。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-26 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1982180
Jaime Tejedor, Francisco J Gutiérrez-Carmona
{"title":"V-pattern with diplopia following bilateral lateral rectus recession in intermittent exotropia.","authors":"Jaime Tejedor, Francisco J Gutiérrez-Carmona","doi":"10.3389/fopht.2026.1982180","DOIUrl":"10.3389/fopht.2026.1982180","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case series of patients presenting with diplopia, V-pattern with esotropia/esophoria, and chin-down head position after bilateral lateral rectus recession (BLR) for the treatment of intermittent exotropia (IXT).</p><p><strong>Methods: </strong>The historical data of patients were recorded, in addition to variables of routine ophthalmological evaluation, including age at onset of IXT; age at BLR; preoperative deviation; magnitude of recessions; postoperative deviation and stereoacuity; ductions and versions; onset and degree of alphabet pattern, diplopia, and chin-down/abnormal head position (AHP); time between the initial BLR and second surgery (inferior displacement of the medial rectus muscles); and degree of correction of the V-pattern, AHP, and diplopia.</p><p><strong>Results: </strong>Six patients were identified. After BLR, two patients had small-angle esotropia, and four had esophoria. The time between surgery and V-pattern development/chin-down position ranged from 2 months to 2 years. Diplopia occurred in five patients. We did not observe inferior oblique overaction, but small subjective excyclotorsion (3°-5°) was detected in four of the six patients. The second surgery occurred around the age of 7 years, except in one patient aged 28 years. The V-pattern and abnormal head position were corrected after medial rectus infraplacement. Orthophoria was observed in five patients and esophoria of 4 prism diopters (PD) in one patient. Subjective torsion was neutralized in only one patient.</p><p><strong>Conclusion: </strong>V-pattern and chin-down position with diplopia may occur after BLR for IXT. We describe successful surgical correction of diplopia and V-pattern/abnormal head position by infraplacement of medial rectus muscles.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1982180"},"PeriodicalIF":2.4,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inverted epiretinal proliferation flap with internal limiting membrane preservation for myopic macular hole retinal detachment: a case report. 内限制膜保存视网膜前增殖瓣治疗近视黄斑孔视网膜脱离1例。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-26 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1960225
Zhi Zhong, Shuxin Cai, Haibo Li
{"title":"Inverted epiretinal proliferation flap with internal limiting membrane preservation for myopic macular hole retinal detachment: a case report.","authors":"Zhi Zhong, Shuxin Cai, Haibo Li","doi":"10.3389/fopht.2026.1960225","DOIUrl":"10.3389/fopht.2026.1960225","url":null,"abstract":"<p><p>In this case report, we describe a 52-year-old woman with high myopia presented with a macular hole retinal detachment for 5 months. Fundus examination showed a full-thickness macular hole with localized retinal detachment, accompanied by both superior and inferior posterior scleral staphylomas. Spectral-domain optical coherence tomography confirmed a large full-thickness macular hole with associated epiretinal proliferation. She underwent 27-gauge vitrectomy using an inverted epiretinal proliferation flap technique without internal limiting membrane peeling, followed by gas tamponade. Postoperatively, the retina was reattached and the macular hole was closed. Best-corrected visual acuity improved from hand motions to 20/200. At the 12-month final follow-up, BCVA remained stable at 20/200, with no evidence of hole reopening or recurrent retinal detachment. This case demonstrates that inverted epiretinal proliferation (ERP) flap with internal limiting membrane (ILM) preservation may represent a feasible tissue-preserving reconstructive strategy for selected patients with myopic macular hole retinal detachment (MHRD) when sufficient ERP is present.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1960225"},"PeriodicalIF":2.4,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Advances and challenges in orbital imaging: from radiography to modern MRI and 3D technologies. 社论:眼眶成像的进展和挑战:从放射摄影到现代MRI和3D技术。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-26 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.2005013
Alon Kahana
{"title":"Editorial: Advances and challenges in orbital imaging: from radiography to modern MRI and 3D technologies.","authors":"Alon Kahana","doi":"10.3389/fopht.2026.2005013","DOIUrl":"10.3389/fopht.2026.2005013","url":null,"abstract":"","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"2005013"},"PeriodicalIF":2.4,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early diagnosis program for multimodal primary open-angle glaucoma based on clinical process. 基于临床过程的多模态原发性开角型青光眼早期诊断方案。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-21 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1975341
Jingyi Ma, Bin Lv, Yuanyuan Li, Pan Fan, Xu Zhao, Yingtao Zhang, Huiping Yuan
{"title":"Early diagnosis program for multimodal primary open-angle glaucoma based on clinical process.","authors":"Jingyi Ma, Bin Lv, Yuanyuan Li, Pan Fan, Xu Zhao, Yingtao Zhang, Huiping Yuan","doi":"10.3389/fopht.2026.1975341","DOIUrl":"10.3389/fopht.2026.1975341","url":null,"abstract":"<p><strong>Background: </strong>Glaucoma is among the leading causes of blindness. It is important to detect glaucoma at early stages. Using structural and functional examinations to identify primary open-angle glaucoma (POAG) is critical. Computer-aided diagnosis of glaucoma requires multimodal data to identify an accurate and explainable model for early glaucoma diagnosis.</p><p><strong>Methods: </strong>In this study, 301 multimodal data points were collected from the ophthalmology department at the Second Affiliated Hospital of Harbin Medical University. Data regarding fundus photography (FP), retinal nerve fiber layer thickness (RNFLt), intraocular pressure (IOP) values, visual field examination parameters and age were obtained. A powerful deep learning network was used to segment the optic nerve head obtained from the FPs. Machine learning classifiers (MLCs) were adopted to obtain the final classification results using 3 datasets: early glaucoma eyes, suspected glaucoma eyes, and healthy eyes; moreover, the diagnostic results of glaucoma specialists and general nonglaucoma ophthalmologists were collected.</p><p><strong>Results: </strong>The overall area under the curve was 0.9858. The accuracy values of the deep learning- machine learning system, the glaucoma specialist group, the general ophthalmologist group were 0.9478, 0.9493, 0.8725, respectively.</p><p><strong>Conclusions: </strong>The algorithm delivers superior results in the early diagnosis of POAG. This study's hybrid deep learning-machine learning framework can effectively assist with clinical decision-making for early POAG.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1975341"},"PeriodicalIF":2.4,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A quantum-inspired cross-attention fusion network for multi-class eye disease classification from retinal fundus images. 基于视网膜眼底图像的多类眼病分类的量子交叉注意融合网络。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-16 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1975827
Abinash P, Krishnamoorthy N
{"title":"A quantum-inspired cross-attention fusion network for multi-class eye disease classification from retinal fundus images.","authors":"Abinash P, Krishnamoorthy N","doi":"10.3389/fopht.2026.1975827","DOIUrl":"10.3389/fopht.2026.1975827","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Automated screening of blinding eye diseases from colour fundus photographs is an active area of medical image analysis, yet many reported systems are validated on a single dataset and offer limited insight into their internal decision process. This study introduces QICAF-Net, a dual-branch deep learning framework that couples a Swin Transformer global-context branch with an EfficientNet local-lesion branch and fuses their representations through a novel Quantum-Inspired Cross-Attention Fusion (QICAF) module. The QICAF module reformulates cross-attention using the mathematical formalism of quantum states: token features are amplitude-encoded as complex unit vectors, transformed by a learnable norm-preserving unitary gate, compared through a fidelity-inspired similarity, normalised by a Born-rule measurement rule, and combined through an entanglement-inspired bilinear interaction. All operations are executed as classical linear algebra on conventional graphics hardware; no physical quantum computer and no quantum speed-up are claimed. The model was trained and evaluated on a balanced four-class retinal dataset of 4,217 fundus images spanning cataract, diabetic retinopathy (DR), glaucoma and normal categories. Under stratified five-fold cross-validation with six-view test-time augmentation (TTA), QICAF-Net attained a macro-F1 of 0.9358 ± 0.0113, an accuracy of 0.9367 ± 0.0112 and a macro one-versus-rest area under the receiver operating characteristic curve (AUC) of 0.9914 ± 0.0023; a three-seed evaluation of the full model gave a macro-F1 of 0.9420 ± 0.0071. An 18-run multi-seed component ablation (six fusion configurations × three seeds) confirmed that the quantum-inspired components achieve accuracy statistically indistinguishable from strong classical fusion baselines, and a paired three-seed significance test between QICAF-Net and a matched dual-branch concatenation model returned no statistically significant accuracy difference (paired t-test p = 0.887; Wilcoxon p = 1.000). Against five single-backbone baselines under an identical preprocessing and TTA protocol, QICAF-Net was competitive but did not exceed the strongest backbones (Swin-Tiny 0.9583, ViT-Small 0.9487). The principal contribution of the module is therefore a novel and interpretable formulation rather than a raw accuracy gain. External validation on a heterogeneous independent cohort (N = 3,907) showed heterogeneous cross-dataset transfer - better preserved for cataract and normal and substantially degraded for glaucoma; under an observed external-domain shift the diabetic-retinopathy sensitivity fell to 39.61%, and under colour-constancy correction with six-view TTA the external accuracy was 0.8741 (95% CI 0.8633-0.8841) and the macro-F1 0.7188 (95% CI 0.6969-0.7398). Two complementary explainability methods together with visualisation of the QICAF attention indicated that the model attends to clinically plausible regions, most strongly the optic nerve head for glaucoma. C","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1975827"},"PeriodicalIF":2.4,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13719398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic literature review and meta-analysis of lotilaner 0.25% and tea tree oil for Demodex blepharitis. 系统文献综述和荟萃分析0.25%洛替拉纳和茶树油治疗蠕形螨眼炎。
IF 2.4
Frontiers in ophthalmology Pub Date : 2026-10-14 eCollection Date: 2026-01-01 DOI: 10.3389/fopht.2026.1978403
Ian Benjamin Gaddie, Mayank A Nanavaty, Timothy Page, Darrell White, Selina McGee, Pamela E Theriot, Noemi Fluetsch Brennan, Lisa Bloudek, James Mun, Elizabeth Yeu, H Burkhard Dick
{"title":"Systematic literature review and meta-analysis of lotilaner 0.25% and tea tree oil for <i>Demodex</i> blepharitis.","authors":"Ian Benjamin Gaddie, Mayank A Nanavaty, Timothy Page, Darrell White, Selina McGee, Pamela E Theriot, Noemi Fluetsch Brennan, Lisa Bloudek, James Mun, Elizabeth Yeu, H Burkhard Dick","doi":"10.3389/fopht.2026.1978403","DOIUrl":"https://doi.org/10.3389/fopht.2026.1978403","url":null,"abstract":"<p><strong>Introduction: </strong><i>Demodex</i> blepharitis (DB) is a common, often underdiagnosed inflammatory eyelid disease caused by <i>Demodex</i> mite infestation. Currently, the only FDA-approved treatment for DB is lotilaner ophthalmic solution, 0.25%. Off-label therapies, including tea tree oil or terpinen-4-ol (collectively referred to as TTO) products, have also been used; however, supporting evidence is inconsistent. This systematic literature review and meta-analysis evaluated the treatment effects and quality of evidence for lotilaner ophthalmic solution, 0.25% and TTO products in patients with DB.</p><p><strong>Methods: </strong>MEDLINE, EMBASE, Cochrane CENTRAL, ClinicalTrials.gov, and ICTRP were searched from inception through July 10, 2025, to identify randomized controlled trials of lotilaner 0.25% or TTO.</p><p><strong>Results: </strong>Nine randomized controlled trials were included, with four evaluating lotilaner 0.25% versus vehicle and five evaluating TTO versus sham, comprising a total of 1,513 patients. Compared with vehicle, lotilaner 0.25% produced significantly lower mite density (mean difference -1.29 mites/lash at both 2-4 and 6-8 weeks; p<0.0001) and significantly higher odds of mite eradication (OR 4.70 at 2-4 weeks; OR 9.60 at 6-8 weeks), collarette reduction to 0-2 collarettes (OR 8.39 and 9.67), and erythema cure at 6-8 weeks (OR 3.91; all p<0.0001). TTO did not demonstrate a statistically significant difference versus sham for mite density or mite eradication at either timepoint.</p><p><strong>Discussion: </strong>These findings demonstrate a consistent, statistically significant benefit of lotilaner 0.25% across assessed outcomes compared with vehicle, supporting lotilaner 0.25% as an effective pharmacological treatment for DB. In contrast, randomized TTO studies were heterogeneous in product concentration, dosing regimen, and sham comparators and did not demonstrate a statistically significant effect on mite density or mite eradication versus sham comparators.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1978403"},"PeriodicalIF":2.4,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13713378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书